𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P148 Screening with holotranscobalamin is superior to serum B12 in identifying vitamin B12 deficiency in patients with Crohn's disease

✍ Scribed by Ward, M.; Kariyawasam, V.; Sobczynska-Malefora, A.; Ajaegbu, A.; Sanderson, J.; Harrington, D.J.; Irving, P.

Book ID
121992573
Publisher
Oxford University Press
Year
2013
Tongue
English
Weight
49 KB
Volume
7
Category
Article
ISSN
1873-9946

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevalence of and risk factors for vitam
Prevalence of and risk factors for vitamin B12 deficiency in patients with Crohn's disease
✍ Peggy D. Headstrom; Stephen J. Rulyak; Scott D. Lee πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 2 views

Background: Crohn's disease (CD) can commonly involve the terminal ileum, which is the site of B 12 absorption. The aim of this study was to define the prevalence of vitamin B 12 abnormalities in a population with CD and to identify risk factors associated with B 12 abnormalities in CD. ## Methods:

Low holotranscobalamin II is the earlies
Low holotranscobalamin II is the earliest serum marker for subnormal vitamin B12 (cobalamin) absorption in patients with AIDS
✍ Victor Herbert; Warren Fong; Veronica Gulle; Tracy Stopler πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 721 KB

In AIDS, as previously found in pernicious anemia (PA), the earliest serum marker of subnormal vitamin B, , (cobalamin) absorption, and therefore of negative B, , balance, is low serum holotranscobalamin II (holo-TC II; B,,-TC II) despite normal total serum B, , level, normal serum homocysteine, and